|
WO2016098838A1
|
|
PEPTIDE, POLYNUCLEOTIDE, VECTOR, TRANSFORMANT, NFκB INHIBITOR, AND THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH ACCELERATED NFκB ACTIVITY
|
|
WO2015108088A1
|
|
Phototherapeutic device for metabolic bone diseases
|
|
WO2010023908A1
|
|
Nanocapsules containing indomethacin and manufacturing method therefor
|
|
WO2009139470A1
|
|
Pharmaceutical composition for treatment of fibromyalgia
|
|
WO2009037839A1
|
|
Method and kit for detection of substance in cell
|
|
WO2009025091A1
|
|
Pharmaceutical composition for treatment of fibromyalgia
|
|
WO2008129896A1
|
|
Method of diagnosing asthenospermia
|
|
WO2008047880A1
|
|
Therapeutic agent for rheumatoid arthritis
|
|
WO2008041751A1
|
|
Pharmaceutical preparation for treating fibromyalgia
|
|
US2009130760A1
|
|
Method for the ubiquitination of common subunit of rna polymerases
|
|
US2009311221A1
|
|
Biomaterials for regenerative medicine
|
|
WO2007000939A1
|
|
Therapeutic agent for local inflammation
|
|
EP1867337A1
|
|
Medicinal composition comprising a fullerene for treating/preventing motor organ disease involving cartilage degeneration
|
|
WO2006001453A1
|
|
NFκB ACTION INHIBITOR AND ANTIINFLAMMATORY AGENT, AND STEROID ACTION FORTIFIER
|
|
WO2005095970A1
|
|
Method of examining rheumatoid arthritis and examination kit
|
|
WO2005061007A1
|
|
Method of suppressing cancer
|
|
WO2004094638A1
|
|
Vasculitis antigen and method of diagnosing vasculitis
|
|
AU4465801A
|
|
Gamma-secretase-like protease inhibitors
|
|
WO0119389A1
|
|
Remedies for rheumatoid arthritis and fused protein
|
|
WO0024427A1
|
|
Remedies for rheumatism containing fadd gene as the active ingredient
|
